IGF2BP2 and hepatocellular carcinoma: In this study, we reveal a novel, methyltransferase‐independent role of PRMT1 in upregulating IGF2BP2 expression in HNSCC, as well as in HCC and lung cancer cells (Figure S13C,D, Supporting Information).